Canada Antirheumatic Medicine Sales is set to reach $179.84 Million by 2026 from $234.85 Million, will fall by 0.7% per year. Germany, Spain and Canada respectively ranked numbers 2, 3 and 4 in this ranking.
How does Canada perform in Anti Rheumatic?
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Canada
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
- Million Canadian Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Export of Heterocyc Compounds and Quinoline Ring from Canada
- Kilograms
- 2024 to 2028
- ReportLinker Research
Forecast: Export of Heterocyc Compounds and Quinoline Ring from Canada
- US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Re-Export of Heterocyc Compounds and Quinoline Ring from Canada
- US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Re-Export of Heterocyc Compounds and Quinoline Ring from Canada
- Kilograms
- 2024 to 2028
- ReportLinker Research